Experimental Hematology
Volume 38, Issue 9 , Pages 744-755 , September 2010

In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V

  • Alexandra Böhm

      Affiliations

    • Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
    • ,
  • Karoline Sonneck

      Affiliations

    • Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
    • ,
  • Karoline V. Gleixner

      Affiliations

    • Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
    • ,
  • Karina Schuch

      Affiliations

    • Institute of Immunology, Medical University of Vienna, Vienna, Austria
    • ,
  • Winfried F. Pickl

      Affiliations

    • Institute of Immunology, Medical University of Vienna, Vienna, Austria
    • ,
  • Katharina Blatt

      Affiliations

    • Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
    • ,
  • Barbara Peter

      Affiliations

    • Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
    • Department of Companion Animals and Horses, Clinic for Internal Medicine and Infectious Diseases, University of Veterinary Medicine Vienna, Vienna, Austria
    • ,
  • Harald Herrmann

      Affiliations

    • Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
    • Ludwig Boltzmann Cluster Oncology, Vienna, Austria
    • ,
  • Gerit-Holger Schernthaner

      Affiliations

    • Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
    • ,
  • Hubert Pehamberger

      Affiliations

    • Department of Dermatology, Medical University of Vienna, Vienna, Austria
    • Ludwig Boltzmann Cluster Oncology, Vienna, Austria
    • ,
  • Werner Rabitsch

      Affiliations

    • Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
    • ,
  • Wolfgang R. Sperr

      Affiliations

    • Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
    • ,
  • Peter Valent

      Affiliations

    • Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
    • Ludwig Boltzmann Cluster Oncology, Vienna, Austria
    • Corresponding Author InformationOffprint requests to: Peter Valent, M.D., Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, AKH-Wien, Waehringer Guertel 18-20, A-1090 Vienna, Austria

Received 6 April 2010 ,Revised 13 May 2010 ,Accepted 18 May 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0301-472X(10)00202-X

doi: 10.1016/j.exphem.2010.05.006

Experimental Hematology
Volume 38, Issue 9 , Pages 744-755 , September 2010

Article Tools

* Image Usage & Resolution